Newsroom
In the following, we will highlight in special "sucess stories" the progress of these projects.
Screening of our European Chemical Biology Library (ECBL) uncovered new modulators of Mitochondria-ER contact sites
Collaboration between ETH Zürich and EU-OPENSCREEN paved the way for ultrafast NMR screening and supported the launch of a promising start-up company
Cooperation between Fabra University in Spain, HZI in Germany and Masaryk University in Czech Republic conducted a screening under BSL3 conditions with exceptional efficiency.
Screening of European Chemical Biology Library revealed small molecules which inhibit a mitochondrial enzyme involved in Alzheimer’s disease
By leveraging EU-OPENSCREEN services, Marcin was able to utilise advanced MALDI-MSI technology to visualise the metabolic alterations induced by OATD-02.
Identification of the Pharmacological Target of Compounds Modulating the Activity of the Cellular Prion Protein (CHEMPRION)
Interfering with RAN translation in ALS – An extensive screening campaign with high-quality laboratory practices